sémaglutide injection effets secondaires Obésité: des médicaments comme Ozempic augmentent le risque de problèmes gastro-intestinaux Perte de poids : les

Patient Adaptation and Management Many patients have found ways to adapt to and manage the gastrointestinal side effects of semaglutide

The United States, also in the OECD group, lags at 7.6% due to coverage limits and supply challenges

"Optimizing Semaglutide Treatment: Balancing Efficacy and Tolerability through Personalized Dosing Approaches." Diabetes, Obesity and Metabolism, 25(5), 1032-1045.

Current Evidence and Clinical Trial Findings Phase 2 data published in the NEJM (2023) showed dose-dependent body weight reductions with retatrutide over 48 weeks, with gastrointestinal side effects being the most commonly reported